Nancy Reau Selected Research

Aligeron (AS 2)

7/2006

Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy Reau Research Topics

Disease

20	Infections 11/2023 - 07/2006
14	Fibrosis (Cirrhosis) 01/2024 - 08/2009
12	Hepatitis C 01/2021 - 07/2006
11	Chronic Hepatitis C 01/2020 - 07/2006
7	Liver Diseases (Liver Disease) 09/2023 - 10/2015
5	Non-alcoholic Fatty Liver Disease 01/2024 - 12/2016
4	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 08/2009
3	Fatigue 09/2022 - 07/2006
2	Liver Neoplasms (Liver Cancer) 11/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 01/2016
2	HIV Infections (HIV Infection) 12/2021 - 08/2009
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 08/2019
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2017
2	Hepatitis B 01/2018 - 12/2016
2	End Stage Liver Disease 01/2016 - 09/2012
2	Ascites 10/2015 - 09/2012
2	Anemia 08/2008 - 07/2006
1	Fatty Liver 12/2022
1	Residual Neoplasm 11/2022
1	Hypoxia (Hypoxemia) 11/2022
1	Neoplasms (Cancer) 11/2022
1	Systemic Mastocytosis 10/2022
1	Jaundice (Icterus) 09/2022
1	Abdominal Pain (Pain, Abdominal) 09/2022
1	Obesity 10/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2021
1	COVID-19 01/2021
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Hemorrhage 10/2020
1	Alcoholism (Alcohol Abuse) 01/2020
1	Alcoholic Fatty Liver 01/2020
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020
1	Hepatitis 01/2018
1	Chronic Disease (Chronic Diseases) 10/2016
1	Hepatic Encephalopathy 01/2016
1	Heart Failure 01/2016
1	Alcoholic Hepatitis 10/2015
1	Brain Diseases (Brain Disorder) 10/2015
1	Hemolytic Anemia 08/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2006

Drug/Important Bio-Agent (IBA)

13	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2013
11	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 07/2006
6	InterferonsIBA 10/2018 - 07/2006
5	SofosbuvirIBA 10/2018 - 12/2015
4	velpatasvirIBA 01/2018 - 12/2015
3	RNA (Ribonucleic Acid)IBA 11/2023 - 10/2017
3	glecaprevir and pibrentasvirIBA 07/2023 - 01/2018
3	AlbuminsIBA 01/2021 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2015
2	Transaminases (Aminotransferases)IBA 09/2022 - 01/2021
2	grazoprevirIBA 01/2020 - 10/2017
2	elbasvirIBA 01/2020 - 10/2017
2	Proton Pump InhibitorsIBA 10/2017 - 01/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2016 - 05/2015
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2013 - 08/2011
2	telaprevirIBA 01/2013 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 08/2008 - 07/2006
1	Immunoglobulin G (IgG)IBA 01/2024
1	SteroidsIBA 01/2024
1	TerlipressinIBA 09/2023
1	tecovirimatIBA 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Carbonic Anhydrase IXIBA 11/2022
1	Epithelial Cell Adhesion MoleculeIBA 11/2022
1	avapritinibIBA 10/2022
1	Thrombopoietin ReceptorsIBA 10/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2019
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2018
1	voxilaprevirIBA 11/2016
1	NucleotidesIBA 11/2016
1	Reducing AgentsIBA 01/2016
1	AcidsIBA 01/2016
1	ElectrolytesIBA 01/2016
1	ZincIBA 10/2015
1	DiureticsIBA 10/2015
1	BilirubinIBA 10/2015
1	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 05/2015
1	asunaprevirIBA 05/2015
1	daclatasvirIBA 05/2015
1	Interferon-alpha (Interferon Alfa)IBA 01/2013
1	peginterferon alfa-2a (Pegasys)FDA Link 08/2008
1	Aligeron (AS 2)IBA 07/2006

Therapy/Procedure

16	Therapeutics 01/2024 - 08/2009
9	Liver Transplantation 01/2024 - 12/2016
1	Drug Therapy (Chemotherapy) 12/2022
1	Highly Active Antiretroviral Therapy (HAART) 09/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Aftercare (After-Treatment) 10/2016
1	Patient Readmission 01/2016
1	Duration of Therapy 11/2015
1	Transplantation 08/2009